128 related articles for article (PubMed ID: 23168379)
1. Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphans.
Li F; Deck JA; Dersch CM; Rothman RB; Deschamps JR; Jacobson AE; Rice KC
Eur J Med Chem; 2012 Dec; 58():557-67. PubMed ID: 23168379
[TBL] [Abstract][Full Text] [Related]
2. Probes for narcotic receptor mediated phenomena. Part 42: synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphans.
Kim JH; Deschamps JR; Rothman RB; Dersch CM; Folk JE; Cheng K; Jacobson AE; Rice KC
Bioorg Med Chem; 2011 Jun; 19(11):3434-43. PubMed ID: 21570305
[TBL] [Abstract][Full Text] [Related]
3. Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity.
Li F; Folk JE; Cheng K; Kurimura M; Deck JA; Deschamps JR; Rothman RB; Dersch CM; Jacobson AE; Rice KC
Bioorg Med Chem; 2011 Jul; 19(14):4330-7. PubMed ID: 21684752
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Pharmacological Evaluation of Enantiopure N-Substituted Ortho-c Oxide-Bridged 5-Phenylmorphans.
Li F; Kopajtic TA; Katz JL; Luo D; Prisinzano TE; Imler GH; Deschamps JR; Jacobson AE; Rice KC
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557961
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological effects of the enantiomers of the N-phenethyl analogues of the ortho and para e- and f-oxide-bridged phenylmorphans.
Zezula J; Singer L; Przybył AK; Hashimoto A; Dersch CM; Rothman RB; Deschamps J; Lee YS; Jacobson AE; Rice KC
Org Biomol Chem; 2008 Aug; 6(16):2868-83. PubMed ID: 18688479
[TBL] [Abstract][Full Text] [Related]
6. Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl analogues of the ortho- and para-d-isomers.
Kurimura M; Liu H; Sulima A; Hashimoto A; Przybyl AK; Ohshima E; Kodato S; Deschamps JR; Dersch CM; Rothman RB; Lee YS; Jacobson AE; Rice KC
J Med Chem; 2008 Dec; 51(24):7866-81. PubMed ID: 19053757
[TBL] [Abstract][Full Text] [Related]
7. Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphans.
Zhang Y; Lee YS; Rothman RB; Dersch CM; Deschamps JR; Jacobson AE; Rice KC
J Med Chem; 2009 Dec; 52(23):7570-9. PubMed ID: 19627147
[TBL] [Abstract][Full Text] [Related]
8. Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylation.
Lim HJ; Dersch CM; Rothman RB; Deschamps JR; Jacobson AE; Rice KC
Eur J Med Chem; 2013 Sep; 67():335-43. PubMed ID: 23880358
[TBL] [Abstract][Full Text] [Related]
9. Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity.
Iyer MR; Lee YS; Deschamps JR; Dersch CM; Rothman RB; Jacobson AE; Rice KC
Eur J Med Chem; 2012 Apr; 50():44-54. PubMed ID: 22341895
[TBL] [Abstract][Full Text] [Related]
10. Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphans.
Cheng K; Lee YS; Rothman RB; Dersch CM; Bittman RW; Jacobson AE; Rice KC
J Med Chem; 2011 Feb; 54(4):957-69. PubMed ID: 21247164
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.
Decker M; Si YG; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2010 Jan; 53(1):402-18. PubMed ID: 19928862
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of rac-(1R,4aR,9aR)-2-methyl-1,3,4,9a-tetrahydro-2H-1,4a-propanobenzofuro[2,3-c]pyridin-6-ol. An unusual double rearrangement leading to the ortho- and para-f oxide-bridged phenylmorphan isomers.
Kodato S; Linders JT; Gu XH; Yamada K; Flippen-Anderson JL; Deschamps JR; Jacobson AE; Rice KC
Org Biomol Chem; 2004 Feb; 2(3):330-6. PubMed ID: 14747861
[TBL] [Abstract][Full Text] [Related]
14. Probes for narcotic receptor-mediated phenomena. 33. Construction of a strained trans-5,6-ring system by displacement of a nitro-activated aromatic fluorine. synthesis of the penultimate oxide-bridged phenylmorphans.
Hashimoto A; Przybyl AK; Linders JT; Kodato S; Tian X; Deschamps JR; George C; Flippen-Anderson JL; Jacobson AE; Rice KC
J Org Chem; 2004 Aug; 69(16):5322-7. PubMed ID: 15287777
[TBL] [Abstract][Full Text] [Related]
15. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
[TBL] [Abstract][Full Text] [Related]
16. Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a micro-agonist delta-antagonist and delta-inverse agonists.
Cheng K; Kim IJ; Lee MJ; Adah SA; Raymond TJ; Bilsky EJ; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Rothman RB; Jacobson AE; Rice KC
Org Biomol Chem; 2007 Apr; 5(8):1177-1190. PubMed ID: 17406716
[TBL] [Abstract][Full Text] [Related]
17. Probes for narcotic receptor mediated phenomena 49. N-substituted rac-cis-4a-arylalkyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols.
Iyer MR; Rothman RB; Dersch CM; Jacobson AE; Rice KC
Eur J Med Chem; 2015 Mar; 92():531-9. PubMed ID: 25599950
[TBL] [Abstract][Full Text] [Related]
18. Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.
McLamore S; Ullrich T; Rothman RB; Xu H; Dersch C; Coop A; Davis P; Porreca F; Jacobson AE; Rice KC
J Med Chem; 2001 Apr; 44(9):1471-4. PubMed ID: 11311071
[TBL] [Abstract][Full Text] [Related]
19. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649
[TBL] [Abstract][Full Text] [Related]
20. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.
Froimowitz M; Pick CG; Pasternak GW
J Med Chem; 1992 May; 35(9):1521-5. PubMed ID: 1315868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
